Status:
COMPLETED
Lidocaine and Tetracaine Cream to Treat Postherpetic Neuralgia (PHN)
Lead Sponsor:
ZARS Pharma Inc.
Conditions:
Postherpetic Neuralgia
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Pliaglis™ (lidocaine and tetracaine) Cream 7%/7% is a topical local anesthetic cream that forms a pliable peel on the skin when exposed to air. When applied to intact skin, Pliaglis provides local der...
Detailed Description
The objectives of the study are 1) to compare the clinical efficacy of lidocaine and tetracaine cream 7%/7% with placebo cream in the treatment of neuropathic pain associated with postherpetic neuralg...
Eligibility Criteria
Inclusion
- Clinical diagnosis of PHN.
- Painful PHN areas not located on the face, eye, or in the hair.
- At least 3 months post-vesicle crusting.
Exclusion
- Has broken skin at the target treatment site.
- Is currently on certain prescription medications.
- Doesn't meet criteria due to physical exam findings or medical history.
- Female that is pregnant, breastfeeding, or of childbearing potential and not practicing adequate birth control.
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT00609323
Start Date
January 1 2008
End Date
September 1 2008
Last Update
March 29 2012
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
ZARS Pharma Clinical Site
Lexington, Kentucky, United States, 40503
2
ZARS Pharma Clinical Site. Reference: SCP-403
High Point, North Carolina, United States, 27262
3
ZARS Pharma Clinical Site. Reference: SCP-403
Winston-Salem, North Carolina, United States, 27103
4
ZARS Pharma Clinical Site
Norman, Oklahoma, United States, 73069